You are here:
DEVELOPMENTAL EFFECTS OF METHYL BENZIMIDAZOLECARBAMATE FOLLOWING EXPOSURE DURING EARLY PREGNANCY
Citation:
Cummings, A., M. Ebron-McCoy, J. Rogers, R. Barbee, AND S. Harris. DEVELOPMENTAL EFFECTS OF METHYL BENZIMIDAZOLECARBAMATE FOLLOWING EXPOSURE DURING EARLY PREGNANCY. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/J-92/116.
Description:
Methyl 2-benzimidazolecarbamate (MBC) and its parent compound benomyl are used as agricultural fungicides. oth chemicals are embryotoxic if administered during organogenesis, and benomyl is teratogenic. ased on a previous study indicating a lack of maternal effects of MBC following exposure during early pregnancy, the current experiments were designed to evaluate the effect of exposure to MBC during early pregnancy on developmental parameters of offspring. ats were administered MBC at 0, 100, 200, 400, or 600 mg/kg/day during Days 1-8 of pregnancy and killed on Day 11 or 20 of gestation. n Day 11, embryos were assessed for survival rate, growth parameters and anomalies. n Day 20, standard developmenta1 toxicity evaluations were performed. xposure to MBC at 100 to 600 mg/kg/day reduced the number of fetuses surviving on Day 20; doses of 200 to 600 mg/kg/day MBC reduced embryonic survival by Day 11. etal weight was reduced by Day 20 and evidence of developmental delay was apparent on Day 11 at all doses. BC produced a dose-dependent increase in several malformations exhibited on Day 20 and in developmental defects seen on Day 11. BC exposure during the first week of pregnancy was shown to be embryotoxic, resulting in embryonic death, growth retardation, and developmental abnormalities when evaluated on Day 11 or 20 of gestation.